Handelsbanken Fonder AB Ups Stake in Amgen by 15.7% During Q2

Handelsbanken Fonder AB increased its stake in Amgen Inc. (NASDAQ:AMGN) by 15.7% during the second quarter, buying an additional 47,052 shares of the medical research company's stock.

The institutional investor now owns 346,596 shares of Amgen's stock, worth $125.51 million as of its most recent filing with the SEC. This represents about 0.06% of Amgen's outstanding shares.

Other hedge funds have also recently added to or reduced their stakes in Amgen. Brighton Jones LLC grew its position in Amgen by 23.5% during the fourth quarter, while Sivia Capital Partners LLC increased its stake in shares of Amgen by 10.6% during the second quarter.

Amgen's commercial portfolio includes biologics used in oncology, supportive care, nephrology, bone health and cardiovascular disease.